Clinical Trial Update: Palonosetron in Sarcoma Patients Receiving Chemotherapy With Adriamycin and Ifosfamide (AI) [NA]

View source ↗

Summary

A completed clinical trial assessed palonosetron for preventing chemotherapy-induced nausea and vomiting in sarcoma patients treated with Adriamycin and ifosfam…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sarcoma

Drugs mentioned

• Aloxi (palonosetron hydrochloride)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Sarcoma, Nausea | NA | Status: COMPLETED | Results posted: 2013-03-22